| Q58568918 | A Higher Preoperative Glycemic Profile Is Associated with Rapid Gastric Emptying After Sleeve Gastrectomy for Obese Subjects |
| Q35904835 | A prospective evaluation of the influence of three bariatric procedures on insulin resistance improvement. Should the extent of undiluted bile transit be considered a key postoperative factor altering glucose metabolism? |
| Q51299440 | Acute improvement in insulin resistance after laparoscopic Roux-en-Y gastric bypass: is 3 days enough to correct insulin metabolism? |
| Q38030832 | Adaptive immunity in obesity and insulin resistance |
| Q47364538 | Adipose tissue mitochondrial respiration and lipolysis before and after a weight loss by diet and RYGB. |
| Q41809362 | Bariatric surgery and T2DM improvement mechanisms: a mathematical model. |
| Q38029253 | Bariatric surgery and bone disease: from clinical perspective to molecular insights. |
| Q37200342 | Bariatric surgery for severe obesity in two adolescents with type 1 diabetes |
| Q35564937 | Bariatric surgery: prevalence, predictors, and mechanisms of diabetes remission |
| Q48103365 | Central Modulation of Energy Homeostasis and Cognitive Performance After Bariatric Surgery |
| Q36838351 | Changes in Adipokines following Laparoscopic Roux-en-Y Gastric Bypass Surgery in Chinese Individuals with Type 2 Diabetes Mellitus and BMI of 22-30 kg·m(-2.). |
| Q37688013 | Childhood obesity for pediatric gastroenterologists. |
| Q55668670 | Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Soc |
| Q34075016 | Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Soc |
| Q92178332 | Clusters of Glycemic Response to Oral Glucose Tolerance Tests Explain Multivariate Metabolic and Anthropometric Outcomes of Bariatric Surgery in Obese Patients |
| Q38915491 | Common Channel Length in Bypass Surgery Does Not Impact T2DM in Diabetic Zucker Rats. |
| Q90465240 | Current State of Bariatric Surgery: Procedures, Data, and Patient Management |
| Q59336864 | Current and future impact of clinical gastrointestinal research on patient care in diabetes mellitus |
| Q35906974 | Defining the role of bariatric surgery in polycystic ovarian syndrome patients |
| Q36959940 | DiaSurg 2 trial--surgical vs. medical treatment of insulin-dependent type 2 diabetes mellitus in patients with a body mass index between 26 and 35 kg/m2: study protocol of a randomized controlled multicenter trial--DRKS00004550. |
| Q51374872 | Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. |
| Q85642681 | Distal Enteral Feeding Helps Blood Sugar Control in Pancreatectomized Patients |
| Q37697736 | Does the length of the biliary limb influence medium-term laboratory remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass in morbidly obese patients? |
| Q34791792 | Dynamics of type 2 diabetes mellitus laboratory remission after Roux-en-Y gastric bypass in patients with body mass index lower than 35 kg/m(2) and higher than 35 kg/m(2) in a 3-year observation period. |
| Q42922758 | Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients. |
| Q51364047 | Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2. |
| Q46421754 | Effects of duodeno-jejunal bypass on glucose metabolism in obese rats with type 2 diabetes |
| Q27316314 | Enhanced Intestinal Motility during Oral Glucose Tolerance Test after Laparoscopic Sleeve Gastrectomy: Preliminary Results Using Cine Magnetic Resonance Imaging |
| Q47094048 | European Guidelines for Obesity Management in Adults. |
| Q26769996 | From bariatric to metabolic surgery: Looking for a "disease modifier" surgery for type 2 diabetes |
| Q43854745 | Gastrectomy for early gastric cancer is associated with decreased cardiovascular mortality in association with postsurgical metabolic changes |
| Q47263095 | Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes |
| Q48372455 | Glycemic Control after Sleeve Gastrectomy and Roux-En-Y Gastric Bypass in Obese Subjects with Type 2 Diabetes Mellitus. |
| Q37727577 | Hormonal signaling in the gut. |
| Q57108687 | Ileal glucose infusion leads to increased insulin sensitivity and decreased blood glucose levels in Wistar rats |
| Q36084126 | Impact of Roux-en-Y gastric bypass on regulation of diabetes type 2 in morbidly obese patients |
| Q49911805 | Impact of gastric emptying and small intestinal transit on blood glucose, intestinal hormones, glucose absorption in the morbidly obese |
| Q37924329 | Impact of laparoscopic adjustable gastric banding on type 2 diabetes. |
| Q28070321 | Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome |
| Q46013901 | Interdisciplinary European Guidelines on metabolic and bariatric surgery. |
| Q53102466 | Interdisciplinary European guidelines on metabolic and bariatric surgery. |
| Q51373663 | Is intestinal gluconeogenesis a key factor in the early changes in glucose homeostasis following gastric bypass? |
| Q46128628 | Laparoscopic gastric bypass for the adolescent patient: long-term results |
| Q48414678 | Laparoscopic reversal of Roux-en-Y gastric bypass: technique and utility for treatment of endocrine complications |
| Q38918743 | Management of type 2 diabetes: the current situation and key opportunities to improve care in the UK. |
| Q51374688 | Metabolic laparoscopic gastric bypass for obese patients with type 2 diabetes. |
| Q28073645 | Metabolic syndrome and the hepatorenal reflex |
| Q37604638 | Metabolic syndrome and the hepatorenal reflex. |
| Q39378705 | Novel Nonsurgical Endoscopic Approaches for the Treatment of Obesity |
| Q38257429 | Nutrition and metabolic support recommendations for the bariatric patient |
| Q35350002 | Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery |
| Q48336786 | Postprandial GLP-2 Levels Are Increased After Biliopancreatic Diversion in Diabetic Individuals with Class I Obesity: a Prospective Study |
| Q38053261 | Potential mechanisms by which bariatric surgery improves systemic metabolism |
| Q90254057 | Predictive factors for diabetes remission after bariatric surgery |
| Q27022123 | Relationship between gut hormones and glucose homeostasis after bariatric surgery |
| Q53648464 | Remission of type 2 diabetes after omega loop gastric bypass for morbid obesity. |
| Q41425474 | Remission of ulcerated necrobiosis lipoidica diabeticorum after bariatric surgery |
| Q50731958 | Resolution of diabetes after bariatric surgery among predominantly African-American patients: race has no effect in remission of diabetes after bariatric surgery. |
| Q38032172 | Resolution of diabetes after pancreaticoduodenectomy in patients with and without pancreatic ductal cell adenocarcinoma |
| Q46447429 | Response to glucose tolerance testing and solid high carbohydrate challenge: comparison between Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and duodenal switch |
| Q38177224 | Role of bariatric surgery in diabetes |
| Q53302682 | Roux-en-Y Esophagojejunostomy Ameliorates Renal Function Through Reduction of Renal Inflammatory and Fibrotic Markers in Diabetic Nephropathy. |
| Q53064729 | Roux-en-Y esophagojejunostomy reduces serum and aortic inflammatory biomarkers in type 2 diabetic rats. |
| Q34653141 | Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial |
| Q47144515 | Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes? |
| Q36949405 | Significant obesity-associated gene expression changes occur in the stomach but not intestines in obese mice |
| Q51357348 | Sleeve gastrectomy improves glucose homeostasis in Zucker diabetic fatty rats. |
| Q51317628 | The effect of duodenojejunostomy and sleeve gastrectomy on type 2 diabetes mellitus and gastrin secretion in Goto-Kakizaki rats. |
| Q49721049 | The effect of hypergastrinemia following sleeve gastrectomy and pantoprazole on type 2 diabetes mellitus and beta-cell mass in Goto-Kakizaki rats |
| Q36826047 | The influence of methods of bariatric surgery for treatment of type 2 diabetes mellitus |
| Q35043446 | The physiology underlying Roux-en-Y gastric bypass: a status report |
| Q37957560 | Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction |